Clinical Trial Update: TPO-RAs Combined With Anti-CD20 Antibody in the Treatment of Adult Immune Thrombocytopenia With Autoantibodies [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update investigating combining thrombopoietin receptor agonists with an anti-CD20 antibody for adults with immune thrombocytopenia and autoantibo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Connective Tissue Diseases
• Evan Syndrome
• Immune Thrombocytopenia

Drugs mentioned

• Rituximab (rituximab)
• Thrombopoietin receptor agonists

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Immune Thrombocytopenia (ITP), Autoantibodies | Phase 2, Phase 3 | Status: UNKNOWN